XTalks
SEPTEMBER 14, 2022
Daxxify was FDA-approved for similar cosmetic purposes as Botox and other neuromodulators like Dysport and Xeomin. Many people choose to undergo non-invasive cosmetic procedures to prevent or reduce the appearance of signs of aging. Daxxify is effective, as safe as competitors, and has been well tolerated in clinical trials.
XTalks
JUNE 17, 2024
RELATED: Innovations and Clinical Trial Diversity in Medical Aesthetics: Insights from Dr. Stephanie Manson Brown, VP & Head of Clinical Development at Allergan Aesthetics – Xtalks Life Science Podcast Ep. 134 How Does Letybo Work?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Olympian Clinical Research
JUNE 2, 2021
At OCR we’re committed to educating the public and raising awareness about diseases like eczema, so today we’re taking some time to walk you through everything you need to know about this common dermatology condition. Triggers can vary patient by patient, but some of the most common eczema triggers are: Cosmetic products. Fragrances.
The Pharma Data
NOVEMBER 4, 2020
Initiated CTP-543 THRIVE-AA1 Phase 3 Trial in November 2020. Initial data from an ongoing long-term, open label extension study with CTP-543 were presented in the late-breaking news session at the European Academy of Dermatology and Venereology (EADV) Virtual Congress on October 29, 2020. G&A Expenses. Net Loss.
XTalks
MAY 22, 2023
It’s an extremely important factor I consider in my therapeutic process of restoring their natural beauty and appearance,” said Macrene Alexiades, MD, PhD, dual US-EU board-certified dermatologist, SkinVive by Juvéderm lead investigator and author of the clinical trial published in Dermatologic Surgery.
XTalks
JULY 5, 2022
XTALKS WEBINAR: Diversity and Inclusion in Clinical Trials — Practical Steps for Patient Recruitment Strategies. Register for this free webinar to learn about the practical steps to be taken towards diversity and inclusion in clinical trials. The trial included 55 subjects over the age of 30 with a wrinkle score of ?
The Pharma Data
NOVEMBER 10, 2020
VPX638 formulation for painful inflammatory conditions is among Vapogenix’s platform of novel, patented formulations of VAs, being developed for the localized treatment of a broad range of painful conditions, including wounds, combat-related injuries, and medical procedures such as needle injections, needle biopsies and cosmetic dermatology.
Expert insights. Personalized for you.
98 
Let's personalize your content